BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 21509910)

  • 41. Immunohistochemical assessment of Ki67 and p53 expression assists the diagnosis and grading of ulcerative colitis-related dysplasia.
    Wong NA; Mayer NJ; MacKell S; Gilmour HM; Harrison DJ
    Histopathology; 2000 Aug; 37(2):108-14. PubMed ID: 10931232
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The fate of low grade dysplasia in ulcerative colitis.
    Ullman TA; Loftus EV; Kakar S; Burgart LJ; Sandborn WJ; Tremaine WJ
    Am J Gastroenterol; 2002 Apr; 97(4):922-7. PubMed ID: 12008669
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prospective study of the progression of low-grade dysplasia in ulcerative colitis using current cancer surveillance guidelines.
    Zisman TL; Bronner MP; Rulyak S; Kowdley KV; Saunders M; Lee SD; Ko C; Kimmey MB; Stevens A; Maurer J; Brentnall TA
    Inflamm Bowel Dis; 2012 Dec; 18(12):2240-6. PubMed ID: 22508402
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Incidence, Risk Factors, and Outcomes of Colorectal Cancer in Patients With Ulcerative Colitis With Low-Grade Dysplasia: A Systematic Review and Meta-analysis.
    Fumery M; Dulai PS; Gupta S; Prokop LJ; Ramamoorthy S; Sandborn WJ; Singh S
    Clin Gastroenterol Hepatol; 2017 May; 15(5):665-674.e5. PubMed ID: 27916678
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Bottom-up cell proliferation with cyclin A and p27Kip1 expression in ulcerative colitis-associated dysplasia.
    Mikami T; Yoshida T; Shiraishi H; Tokuyama W; Motoori T; Okayasu I
    Pathol Int; 2006 Jan; 56(1):10-6. PubMed ID: 16398674
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Immunohistochemical expression of P53 and oncogenes in ulcerative colitis-associated colorectal carcinoma.
    Brüwer M; Schmid KW; Senninger N; Schürmann G
    World J Surg; 2002 Mar; 26(3):390-6. PubMed ID: 11865380
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Wnt pathway-related gene expression during malignant progression in ulcerative colitis.
    van Dekken H; Wink JC; Vissers KJ; Franken PF; Ruud Schouten W; J Hop WC; Kuipers EJ; Fodde R; Janneke van der Woude C
    Acta Histochem; 2007; 109(4):266-72. PubMed ID: 17445872
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Midkine expression in colorectal tumors: correlation with Ki-67 labeling in sporadic, but not ulcerative colitis-associated ones.
    Tokuyama W; Mikami T; Fujiwara M; Matsui T; Okayasu I
    Pathol Int; 2007 May; 57(5):260-7. PubMed ID: 17493173
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Systematic review with meta-analysis: incidence and factors for progression to advanced neoplasia in inflammatory bowel disease patients with indefinite and low-grade dysplasia.
    Wan J; Wang X; Zhang Y; Chen M; Wang M; Wu K; Liang J
    Aliment Pharmacol Ther; 2022 Mar; 55(6):632-644. PubMed ID: 35166389
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Expression of activation-induced cytidine deaminase in ulcerative colitis-associated carcinogenesis.
    Gushima M; Hirahashi M; Matsumoto T; Fujita K; Ohuchida K; Oda Y; Yao T; Iida M; Tsuneyoshi M
    Histopathology; 2011 Sep; 59(3):460-9. PubMed ID: 22034886
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Molecular alterations in colitis-associated colorectal neoplasia: study from a low prevalence area using magnifying chromo colonoscopy.
    Shivakumar BM; Kumar BL; Bhat G; Suvarna D; Rao L; Pai CG; Satyamoorthy K
    J Crohns Colitis; 2012 Jul; 6(6):647-54. PubMed ID: 22398042
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Long-term Risk of Advanced Neoplasia After Colonic Low-grade Dysplasia in Patients With Inflammatory Bowel Disease: A Nationwide Cohort Study.
    De Jong ME; Van Tilburg SB; Nissen LHC; Kievit W; Nagtegaal ID; Horjus CS; Römkens TEH; Drenth JPH; Hoentjen F; Derikx LAAP
    J Crohns Colitis; 2019 Dec; 13(12):1485-1491. PubMed ID: 31175827
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Progression to colorectal neoplasia in ulcerative colitis: effect of mesalamine.
    Ullman T; Croog V; Harpaz N; Hossain S; Kornbluth A; Bodian C; Itzkowitz S
    Clin Gastroenterol Hepatol; 2008 Nov; 6(11):1225-30; quiz 1177. PubMed ID: 18848502
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immunohistochemical assessment of a unique basal pattern of p53 expression in ulcerative-colitis-associated neoplasia using computer-assisted cytometry.
    Kobayashi S; Fujimori T; Mitomi H; Tomita S; Ichikawa K; Imura J; Fujii S; Itabashi M; Kameoka S; Igarashi Y
    Diagn Pathol; 2014 May; 9():99. PubMed ID: 24886509
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dysplasia is more common in the distal than proximal colon in ulcerative colitis surveillance.
    Goldstone R; Itzkowitz S; Harpaz N; Ullman T
    Inflamm Bowel Dis; 2012 May; 18(5):832-7. PubMed ID: 21739534
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Expression of p53 as predictor for the development of esophageal cancer in achalasia patients.
    Leeuwenburgh I; Gerrits MM; Capello A; van den Bogert B; van Dekken H; Steyerberg EW; Siersema PD; Kuipers EJ
    Dis Esophagus; 2010 Aug; 23(6):506-11. PubMed ID: 20113324
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dysplasia-like epithelial atypia in ischemic bowel disease.
    Abraham SC; Taggart MW; Loftus EV; Wu TT
    Hum Pathol; 2014 Jul; 45(7):1348-57. PubMed ID: 24946975
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immunohistochemical expression of cyclin D1, cyclin E, p21/waf1 and p27/kip1 in inflammatory bowel disease: correlation with other cell-cycle-related proteins (Rb, p53, ki-67 and PCNA) and clinicopathological features.
    Ioachim EE; Katsanos KH; Michael MC; Tsianos EV; Agnantis NJ
    Int J Colorectal Dis; 2004 Jul; 19(4):325-33. PubMed ID: 15060836
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Immunohistochemical evaluation of a panel of tumor cell markers during malignant progression in Barrett esophagus.
    van Dekken H; Hop WC; Tilanus HW; Haringsma J; van der Valk H; Wink JC; Vissers KJ
    Am J Clin Pathol; 2008 Nov; 130(5):745-53. PubMed ID: 18854267
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Expression Profile of p53 and p21 in Large Bowel Mucosa as Biomarkers of Inflammatory-Related Carcinogenesis in Ulcerative Colitis.
    Popp C; Nichita L; Voiosu T; Bastian A; Cioplea M; Micu G; Pop G; Sticlaru L; Bengus A; Voiosu A; Mateescu RB
    Dis Markers; 2016; 2016():3625279. PubMed ID: 27578918
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.